For example, if you started semaglutide in 2024 with a BMI of 37 and your BMI has since dropped to 32, you still qualify
Matthews DR, Paldnius PM, Proot P et al (2019) Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
In some cases, patients may take microdoses as part of a titration process, slowly increasing as tolerated
Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study
Medications For Weight Loss Dual GIP & GLP-1 Receptor Agonist Mimics the GLP-1 hormone to reduce hunger, slow digestion, and increase fullness Combines two hormones to curb appetite, improve blood sugar, and boost fat burning Once-weekly injection or daily oral tablet
The good news is that these dysesthesia events were generally mild
.png.jpg)
